If PAP is diagnosed during immunosuppressive treatment, physicians should consider that immunosuppressive treatment may exacerbate PAP and titrate immunosuppressive drugs regardless of KL-6 levels if other findings show an improvement in IP. Here, MUC1 is linked to pulmonary alveolar proteinosis.